E., Iskandar, M
Missing doses can impact the overall effectiveness of the treatment
Given its excellent safety profile, NAC should be considered an effective adjuvant across most chronic and infectious respiratory conditions, with limited evidence only in asthma and interstitial lung diseases
Eur J Endocrinol 136:4551 Mauras N, O'Brien KO, Welch S, Rini A, Helgeson K, Vieira NE, Yergey AL (2000) Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism
Nonetheless, two IV studies have been published related to Parkinsons disease, one open-label which found significant improvement and a slowing of the disease, and one randomized and double-blinded which found only mild symptomatic improvement